文献速递颈动脉与弓上血管

牛心包补片与其他补片材料用于颈动脉内膜切除术的随机试验荟萃分析

A meta-analysis of randomized trials comparing bovine pericardium and other patch materials for carotid endarterectomy.
PubMed 文献 · J Vasc Surg · 2018-01-01

本研究按PRISMA指南检索截至2017年9月的随机对照试验,纳入18项研究共3234例患者,采用随机效应模型荟萃分析。结果显示合成补片与静脉补片、聚四氟乙烯与涤纶补片、牛心包与合成补片在30天卒中、短暂性脑缺血发作、死亡及远期再狭窄等终点上均无统计学显著差异。作者认为各补片材料短期和长期终点似乎相似,但需更多随访充分的随机试验比较牛心包补片与其他补片。

要点

  • 纳入18项随机试验共3234例患者,比较合成、静脉与牛心包补片用于颈动脉内膜切除术。
  • 合成补片与静脉补片在30天卒中、短暂性脑缺血发作、死亡及远期再狭窄>50%等终点上均无统计学显著差异。
  • 牛心包补片与合成补片在30天卒中、短暂性脑缺血发作、颈部局部血肿和死亡上均无统计学显著差异。

核心结论

  • 使用所研究的任一补片材料关闭颈动脉切口在短期和长期终点上似乎相似,但需更多随访充分的随机试验比较牛心包补片与其他补片材料。

研究设计与样本

  • 按PRISMA指南行系统综述与荟萃分析,检索PubMed、Scopus和Cochrane Central截至2017年9月发表的随机对照试验,采用随机效应模型,纳入18项研究共3234例患者。

主要发现

  • 合成补片与静脉补片比较:30天卒中相对风险1.00(95%CI 0.45-2.19;I²=0%),短暂性脑缺血发作相对风险1.14(95%CI 0.41-3.19;I²=0%),心肌梗死比值比0.75(95%CI 0.14-3.97;I²=0%),死亡相对风险0.53(95%CI 0.21-1.34;I²=0%),伤口感染相对风险1.84(95%CI 0.43-7.81;I²=0%),颈动脉血栓形成相对风险1.47(95%CI 0.44-4.97;I²=0%),颅神经麻痹相对风险1.21(95%CI 0.53-2.77;I²=0%),远期卒中相对风险2.33(95%CI 0.76-7.10;I²=0%),远期死亡相对风险1.09(95%CI 0.65-1.83;I²=0%),再狭窄>50%相对风险0.48(95%CI 0.19-1.20;I²=0%),均无统计学显著差异。
  • 聚四氟乙烯补片与涤纶补片比较:30天卒中相对风险0.31(95%CI 0.02-5.16;I²=63.1%),短暂性脑缺血发作相对风险0.49(95%CI 0.14-1.76;I²=0%),死亡相对风险0.74(95%CI 0.05-10.51;I²=31.7%),颈动脉血栓形成相对风险0.13(95%CI 0.02-1.07;I²=0%),远期再狭窄>70%相对风险0.15(95%CI 0.01-2.29;I²=70.9%),均无统计学显著差异。
  • 牛心包补片与合成补片比较:30天卒中相对风险1.44(95%CI 0.19-10.79;I²=12.7%),短暂性脑缺血发作相对风险1.05(95%CI 0.11-10.27;I²=0%),颈部局部血肿相对风险4.01(95%CI 0.46-34.85;I²=0%),死亡相对风险4.01(95%CI 0.46-34.85;I²=0%),均无统计学显著差异。

关键数值与推荐

  • 主要终点为远期再狭窄发生率;次要终点包括30天卒中、短暂性脑缺血发作、心肌梗死、颈部伤口感染、局部血肿、颈动脉血栓形成、颅神经损伤、远期卒中发生率和死亡。

临床怎么用

  • 作者认为使用所研究的任一补片材料关闭颈动脉切口在短期和长期终点上似乎相似。
  • 作者提出需更多随访充分的随机试验比较牛心包补片与其他补片材料。

局限性

  • 牛心包补片与合成补片比较的30天卒中、短暂性脑缺血发作、颈部局部血肿和死亡等分析置信区间宽。
  • 聚四氟乙烯与涤纶补片比较中30天卒中(I²=63.1%)和远期再狭窄>70%(I²=70.9%)存在异质性。
  • 作者指出需更多随访充分的随机试验比较牛心包补片与其他补片材料。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patch angioplasty during carotid endarterectomy is commonly used to treat symptomatic and asymptomatic carotid artery stenosis. The objective of the present study was to compare the different patch materials that are currently available (synthetic vs venous vs bovine pericardium) in terms of short- and long-term outcomes. METHODS: This study was performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines and eligible randomized control trials were identified through a comprehensive search of PubMed, Scopus, and Cochrane Central published until September 2017. A meta-analysis was conducted with the use of a random effects model. The I2 statistic was used to assess for heterogeneity. The primary study end point was the incidence of long-term restenosis. Secondary study end points were 30-day stroke, transient ischemic attack (TIA), myocardial infarction, neck wound infection, local hematoma, carotid artery thrombosis, cranial nerve injury, long-term stroke incidence, and death. RESULTS: Eighteen studies and 3234 patients were included. The risk of 30-day stroke (relative risk [RR], 1.00; 95% confidence interval [CI], 0.45-2.19; I2 = 0%), TIA (RR, 1.14; 95% CI, 0.41-3.19; I2 = 0%), myocardial infarction (odds ratio, 0.75; 95% CI, 0.14-3.97; I2 = 0%), death (RR, 0.53; 95% CI, 0.21-1.34; I2 = 0%), wound infection (RR, 1.84; 95% CI, 0.43-7.81; I2 = 0%), carotid artery thrombosis (RR, 1.47; 95% CI, 0.44-4.97; I2 = 0%), cranial nerve palsy (RR, 1.21; 95% CI, 0.53-2.77; I2 = 0%), and long-term stroke (RR, 2.33; 95% CI, 0.76-7.10; I2 = 0%), death (RR, 1.09; 95% CI, 0.65-1.83; I2 = 0%) and restenosis of greater than 50% (RR, 0.48; 95% CI, 0.19-1.20; I2 = 0%) were similar between the synthetic vs venous patch groups. Also, no differences in terms of 30-day stroke (RR, 0.31; 95% CI, 0.02-5.16; I2 = 63.1%), TIA (RR, 0.49; 95% CI, 0.14-1.76; I2 = 0%), death (RR, 0.74; 95% CI, 0.05-10.51; I2 = 31.7%), carotid artery thrombosis (RR, 0.13; 95% CI, 0.02-1.07; I2 = 0%), and long-term restenosis of greater than 70% (RR, 0.15; 95% CI, 0.01-2.29; I2 = 70.9%) were detected between the synthetic polytetrafluoroethylene and Dacron patch groups. The comparison between the bovine pericardium vs synthetic patch did not yield any statistically significant results in terms of 30-day stroke (RR, 1.44; 95% CI, 0.19-10.79; I2 = 12.7%), TIA (RR, 1.05; 95% CI, 0.11-10.27; I2 = 0%), local neck hematoma (RR, 4.01; 95% CI, 0.46-34.85; I2 = 0%), and death (RR, 4.01; 95% CI, 0.46-34.85; I2 = 0%). CONCLUSIONS: Closure of the carotid arteriotomy with any of the studied patch materials seems to be similar in terms of short- and long-term end points. However, additional randomized trials with adequate follow-up periods are needed to compare bovine pericardium patches with other patch materials.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Texakalidis P, Giannopoulos S, Charisis N, et al. A meta-analysis of randomized trials comparing bovine pericardium and other patch materials for carotid endarterectomy. J Vasc Surg. 2018. PMID: 30244928. doi:10.1016/j.jvs.2018.07.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。